Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Emergex Vaccines Holding Limited, a biotechnology company pioneering a new approach to synthetic vaccine development in the field of infectious diseases, today announces the successful completion of preclinical toxicology testing on the gold nanoparticle carrier system that forms the fundamental basis for Emergex's entire infectious disease vaccine platform.

24 Oct 2018

Federal court orders Tennessee-based company to stop selling OTC drug products

A federal court ordered a Tennessee-based company to stop selling over-the-counter (OTC) drug products until the company complies with the Federal Food, Drug, and Cosmetic Act and other requirements listed in a consent decree.

24 Oct 2018

A major grant funds curiosity-driven research into plant communication

A major grant to fund curiosity-driven research into plant communication has been awarded to a John Innes Centre researcher and colleagues from two European institutes.

24 Oct 2018

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Polyganics today announced that it has initiated enrollment of patients into a first-in-human clinical trial of LIQOSEAL, its dura sealant patch.

23 Oct 2018

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Novartis announced today that the full data from the LIBERTY study of Aimovig (erenumab) in episodic migraine patients who had tried and failed two to four prior preventive treatments have been published in the Lancet.

23 Oct 2018

Stratasys to showcase potential of 3D printed models at MEDICA 2018

This year’s MEDICA World Forum for Medicine (Düsseldorf, 12-15 November) will see Stratasys (Hall 9, Stand D12) demonstrate how medical institutions and their suppliers throughout the world are using advanced 3D printing across the entire value chain.

22 Oct 2018

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck, known as MSD outside the United States and Canada, today announced the first presentation of preliminary data from a Phase 1 clinical trial evaluating MK-1454, an investigational STING (stimulator of interferon genes) agonist, as monotherapy and in combination with KEYTRUDA (pembrolizumab), Merck's anti-PD-1 therapy, in patients with advanced solid tumors or lymphomas.

22 Oct 2018

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Merck, known as MSD outside the United States and Canada, today announced the first presentation of results from an interim analysis of KEYNOTE-057, a Phase 2 trial evaluating KEYTRUDA, Merck's anti-PD-1 therapy, for previously treated patients with high-risk non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ or CIS plus papillary disease (Cohort A).

22 Oct 2018

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Incyte Corporation announces updated data from its ongoing Phase 2 FIGHT-202 trial evaluating pemigatinib (INCB54828), its selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced/metastatic or surgically unresectable cholangiocarcinoma (bile duct cancer) who failed at least one previous treatment.

22 Oct 2018

Newly discovered compound shows potential for treating Parkinson's disease

A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physiology of the Keio University School of Medicine, together with a research group of Eisai Co., Ltd. has identified a compound that has the potential to be a treatment for Parkinson's disease by using dopaminergic neurons differentiated from induced pluripotent stem (iPS) cells from patients with familial Parkinson's disease.

19 Oct 2018

Middlemen suppliers can increase drug prices and hospital bills, say Johns Hopkins researchers

Hospitals should be cautious of group purchasing organizations, or entities that act as middlemen between health care providers and manufacturers, says Martin Makary, M.D., M.P.H., a professor of surgery at the Johns Hopkins University School of Medicine.

19 Oct 2018

Key insights into the application, production of bioactive materials

Anatomy, Modeling and Biomaterial Fabrication for Dental and Maxillofacial Applications provides readers with information about dental implants and biomaterial fabrication for maxillofacial procedures and dental bone / tissue repair.

19 Oct 2018

Metrohm software products make it easy to comply with ALOCA and ALCOA+ guidelines

Data integrity requires data to be complete, consistent, and accurate throughout their complete lifecycle, providing full transparency and traceability.

From Metrohm USA Inc. 17 Oct 2018

Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant

Eisai Co., Ltd. and Purdue Pharma L.P. announced positive topline results from SUNRISE 2, a long-term Phase 3 efficacy and safety evaluation of lemborexant, an investigational agent for sleep-wake regulation currently being studied for the potential treatment of multiple sleep-wake disorders.

17 Oct 2018

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Eisai Co., Ltd. has entered into an agreement to grant exclusive development and marketing rights for its anti-obesity agent lorcaserin hydrochloride (generic name, product name in the United States: BELVIQ, product name for once-daily formulation in the United States: BELVIQ XR, "lorcaserin") in 17 countries in Latin America and the Caribbean, excluding Brazil, to Eurofarma Laboratorios S.A. which has a business foundation in Latin America.

16 Oct 2018

Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus

A new Kaiser Health News database tracks campaign donations from drugmakers over the past 10 years.

16 Oct 2018

Researchers demonstrate integrated technique to control production of cell therapeutics

Researchers have demonstrated an integrated technique for monitoring specific biomolecules - such as growth factors - that could indicate the health of living cell cultures produced for the burgeoning field of cell-based therapeutics.

15 Oct 2018

Lab Innovations to host new range of laboratory product launches in Birmingham

Lab Innovations, the UK’s only trade show dedicated to the laboratory industry, will again host a range of laboratory introductions during the event at the NEC, Birmingham, on 31st October to 1st November.

From Lab Innovations 12 Oct 2018

KNAUER high-pressure dosing pumps contribute to the success of Grillo’s new MSA synthesis

The Berlin-based manufacturer of laboratory measuring instruments KNAUER Wissenschaftliche Geräte GmbH reported today, that its high-pressure metering pumps played an important role in the development of the groundbreaking new manufacturing process of methanesulfonic acid directly from methane and sulfur trioxide, which was successfully realized by researchers from Duisburg's Grillo-Werke AG.

From KNAUER Wissenschaftliche Geräte GmbH 12 Oct 2018

Self-care polymers fibers recognize need for therapy

Drug-releasing textiles could, for instance, be used to treat skin wounds. Empa researchers are currently developing polymer fibers that can be equipped with drugs. The smart fibers recognize the need for therapy all by themselves and dose the active ingredients with precision and accuracy.

12 Oct 2018

Manufacturing News and Research

Further Reading

Emergex completes toxicology testing on gold nanoparticle carrier system for vaccine platform

Federal court orders Tennessee-based company to stop selling OTC drug products

A major grant funds curiosity-driven research into plant communication

Polyganics begins first-in-human clinical trial of LIQOSEAL for reducing CSF leakage

Novartis: Lancet publishes pioneering study of Aimovig’s efficacy in episodic migraine patients

Stratasys to showcase potential of 3D printed models at MEDICA 2018

Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas

Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer

Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma

Newly discovered compound shows potential for treating Parkinson's disease

Middlemen suppliers can increase drug prices and hospital bills, say Johns Hopkins researchers

Key insights into the application, production of bioactive materials

Metrohm software products make it easy to comply with ALOCA and ALCOA+ guidelines

Purdue Pharma, Eisai announce positive topline results from Phase 3 study of lemborexant

Eisai enters into agreement with Eurofarma for development and sales of lorcaserin in 17 countries

Drugmakers funnel millions to lawmakers; a few dozen get $100,000-plus

Researchers demonstrate integrated technique to control production of cell therapeutics

Lab Innovations to host new range of laboratory product launches in Birmingham

KNAUER high-pressure dosing pumps contribute to the success of Grillo’s new MSA synthesis

Self-care polymers fibers recognize need for therapy

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®